Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 0 | 0 | 5,854 |
| Gross Profit | N/A | N/A | N/A | N/A | 5,854 |
| Operating Expenses | 10,014 | 11,879 | 6,764 | 8,184 | 18,546 |
| Operating Income | -10,014 | -11,879 | -6,764 | -8,184 | -12,692 |
| Interest Expense | 19 | 444 | 696 | 598 | 210 |
| Other Income | 110 | 6,037 | 1,760 | -7,821 | 172 |
| Pre-tax Income | -9,922 | -6,286 | -5,700 | -16,603 | -12,730 |
| Income Tax | -1 | -3,271 | N/A | N/A | -2,634 |
| Net Income Continuous | -9,922 | -3,015 | -5,700 | -16,603 | -10,096 |
| Net Income | $-9,922 | $-3,015 | $-5,700 | $-16,603 | $-10,096 |
| EPS Basic Total Ops | 6.80 | -0.60 | -7.20 | -12.40 | 4.00 |
| EPS Basic Continuous Ops | 4.44 | -0.66 | -2.38 | -11.11 | 3.47 |
| EPS Diluted Total Ops | 6.80 | -0.60 | -7.20 | -12.40 | 4.00 |
| EPS Diluted Continuous Ops | 4.44 | -0.66 | -2.38 | -11.11 | 3.47 |
| EBITDA(a) | $-9,934 | $-11,757 | $-6,587 | $-8,009 | $-11,803 |